Open Medicine (Jan 2021)
Comparison of single and double autologous stem cell transplantation in multiple myeloma patients
Abstract
Autologous stem cell transplantation (ASCT) is one of the standard treatments of choice for eligible multiple myeloma (MM) patients. Herein, we aimed to analyze MM patients at our center and compare the clinical outcomes of single and double ASCT patients.
Keywords